Oklo Inc (NYSE:OKLO) approval of NSDA.
Article excerpt
Highlighted: the sentence this signal was extracted from
Oklo Inc (NYSE:OKLO) approval of NSDA. Oklo Inc (NYSE:OKLO) stock rose 0.10% (As on March 18, 11:21:11 AM UTC-4, Source: Google Finance) after the company announced the U.S. Department of Energy (DOE) approved its Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy's Groves Isotopes Test Reactor in Texas under the DOE's Reactor Pilot Program. Oklo broke ground on its first Aurora powerhouse in September. The company said that it continues to target the deployment of its first powerhouse in 2028. Oklo marked one of the major milestones by receiving its first materials license from the U.S. Nuclear Regulatory Commission (NRC) for its subsidiary, Atomic Alchemy. This approval allows the company to handle, process and distribute isotopes from its Idaho Radiochemistry Laboratory. The license enables the recovery and refinement of materials such as Ra-226, alongside the use of Co-60 and Am-241 for calibration purposes. This development is particularly significant given the growing demand for critical isotopes in medicine, research and industrial applications. Moreover, Oklo reported a loss of 27 cents per share for the fourth quarter, missing analyst estimates for a loss of 16 cents per share. The pre-revenue company reported operating losses of $139.3 million in 2025. Oklo noted that it expects "significant ongoing operating expenditures" will be necessary to develop...
Keep reading with a free account
The rest of this article, and every signal for Oklo, is in your free account.
